Flexion Therapeutics (FLXN) Reports Q4 Loss of $1.97

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. CVS
10. SPY

Go back to Flexion Therapeutics (FLXN) Reports Q4 Loss of $1.97

Flexion Reports Year-End 2014 Financial Results

March 23, 2015 4:05 PM EDT

Strong cash position bolstered through IPO and follow-on financing, raising a combined total of over $173 million Lead drug candidate FX006 advanced into late-stage pivotal trials for patients with osteoarthritis (OA) of the knee

BURLINGTON, Mass., March 23, 2015 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN) today announced financial results for the year-ended December 31, 2014.

In February 2014, the successful completion of an initial public offering of Flexion common stock raised gross proceeds of... More